The research laboratory of Dr. Wayne Frankel seeks a postdoctoral research scientist to study genetic mechanisms of brain disease. The group's specific interests are in developing and characterizing new mouse models of epilepsy and related neurological disorders accompanied by recurrent seizures, through understanding mechanisms that regulate synaptic development and function at physiological and/or molecular levels. The position also provides an opportunity to combine genetic modeling with preclinical phenotyping and physiology towards the development of therapies based on precision genetics.
Competitive applicants will have completed their Ph.D. and published one or more first author research articles in leading journals. We seek applicants who are especially motivated to take advantage of this unique opportunity to advance their careers by combining their existing neuroanatomy, imaging or neurophysiology expertise with genetic analysis and disease modeling. There will also opportunities to collaborate with other faculty as the IGM grows.
The IGM seeks to comprehensively integrate genetics and genomics into research, training and patient care and to develop programs that prepare students for careers as researchers and clinicians in the expanding field of genomic medicine.
Columbia University is an Equal Opportunity/Affirmative Action employer --Race/Gender/Disability/Veteran.
To apply, please go to: http://academicjobs.columbia.edu/applicants/Central?quickFind=65668
Candidates should have or be very close to obtaining a Ph.D. in a relevant field, and have less than five years of postdoctoral experience.
Competitive applicants should have completed their Ph.D. and published one or more first author research articles in leading journals.
The Institute for Genomic Medicine is driving innovation in genomic medicine through cutting-edge research, clinical applications and outreach efforts. Our multi-tiered approach to genomic medicine utilizes large scale genomic sequencing and analysis, paired with functional biology to advance the diagnosis, characterization, and treatment of genetic diseases. As part of Columbia University's ove...rall Precision Medicine Initiative, we are fully integrated into the research and clinical communities at Columbia University and NewYork-Presbyterian, and will utilize our expertise in genome sequencing, disease biology, and electronic medical records to develop and advance patient-centered precision medicine.